Drug Type Small molecule drug |
Synonyms Lymecycline (INN), N-Lysinomethyltetracycline, N2-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline + [3] |
Target |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), Protein biosynthesis inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC29H38N4O10 |
InChIKeyAHEVKYYGXVEWNO-UEPZRUIBSA-N |
CAS Registry992-21-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06884 | Lymecycline |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infectious Diseases | - | - | - |
Phase 3 | 378 | (Adapalene 0.1% / BPO 2.5% Gel + Lymecycline) | kafygvrraa(bqkkbhscta) = kiavmlxzjq kkrqorowww (umijtlxapk, dhzvendpgo - throfaawhi) View more | - | 05 Apr 2012 | ||
Lymecycline+Adapalene (Adapalene 0.1% / BPO 2.5% Vehicle Gel + Lymecycline) | kafygvrraa(bqkkbhscta) = ziytukdrbt kkrqorowww (umijtlxapk, qniwszgxrz - hpctgszthp) View more |